PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Linden closes USD375m investment fund

Linden, a Chicago-based healthcare focused private equity firm, has completed fundraising for Linden Capital Partners II, which closed with USD375m of committed capital and exceeded its target of USD300m and initial cap of USD350m.

Linden’s second fund continues the strategy from its first fund, executed through industry specialisation in healthcare and life science, a focus on building and maintaining corporate relationships, and integrating operating partners in investment decisions and management. 

Linden received strong support from its institutional investors, 100 per cent of whom reinvested in LCP II. In addition, the firm attracted new global LPs, state pension plans, foundations, funds of funds, and family offices.

Linden founder and partner Eric Larson says: "We are pleased to have exceeded our fundraising target in a very demanding environment. This was definitely a team effort, involving the entire Linden organisation as well as the talented managers at our portfolio companies." 

LCP II follows Linden’s first fund of USD200m, established in 2006. 

Park Hill Group served as placement agent for LCP II, and Kirkland & Ellis served as legal counsel.

Like this article? Sign up to our free newsletter

FEATURED

MOST RECENT

FURTHER READING